Search results
Showing 3046 to 3060 of 9026 results
DMD Care UK's guideline on respiratory care: NICE review (NR2)
NICE has reviewed DMD Care UK’s guideline on respiratory care for Duchenne muscular dystrophy. We think the guideline from DMD Care UK is a useful resource that will help healthcare professionals improve care in this area
Evidence-based recommendations on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.
View recommendations for AMR1Show all sections
Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (AMR2)
Evidence-based recommendations on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.
Details of the business expenses incurred by the board and senior management team in delivery of their duties.
Home About us Our board Public board meetings...
NICE works with partners including Public Health England, NHS England and NHS Improvement to assess services and support innovation and best practice.
Find guidance, advice and information for health, public health and social care professionals.
IMI and H2020 Grant funded projects with NICE
Our guidance is developed by independent committees, including professionals and lay members, and consulted on by stakeholders.
NICE's past research and projects
Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Agenda and papers of the NICE public board meeting on 10 December 2025
Agenda and papers of the NICE public board meeting on 19 March 2025
Agenda and papers of the NICE public board meeting on 22 July 2025
Research to access pathway for investigational drugs for COVID-19 (RAPID C-19)
RAPID C-19’s role in reviewing potential COVID-19 treatments has now ended because we have moved back to routine commissioning arrangements for these treatments.